Seminars in Interventional Radiology Seminars in Interventional Radiology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Advanced Imaging Techniques Used in Direct Portosystemic Shunt Creation in Budd-Chiari Syndrome with Complex Venous Anatomy
Semin intervent Radiol 2024; 41: 097-102 DOI: 10.1055/s-0044-1779712 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Rostami, Sara Fickert, Jaclyn Morris, Connor Samuel, Michael Vu, Doan Ray, Charles E. Kord, Ali Tags: Technical Corner Source Type: research

A Simple “Involute” Technique for Successful Removal of a Caudally Migrated “Viatorr” Stent Graft
Semin intervent Radiol 2024; 41: 092-096 DOI: 10.1055/s-0044-1779710 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Zhou, Vellia Reddick, Mark Lamus, Daniel Arellano, Ronald S. Kalva, Sanjeeva P. Tags: Technical Corner Source Type: research

Biologics, Immunotherapies, and Cytotoxic Chemotherapy for Hepatocellular Carcinoma following Current Recommendations by the BCLC: A Review of Agents
Semin intervent Radiol 2024; 41: 084-091 DOI: 10.1055/s-0043-1778660 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Gurtatta, Rajangad S. Whalen, Sydney E. Ray, Charles E. Tags: Clinical Corner Source Type: research

Embolic Agents: Sclerotherapy
Semin intervent Radiol 2024; 41: 079-083 DOI: 10.1055/s-0043-1778656 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Lim, Christina Lee, Sean Ghosh, Abheek Funaki, Brian Tags: Back to Basics Source Type: research

Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips
Semin intervent Radiol 2024; 41: 063-078 DOI: 10.1055/s-0044-1779715 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Villalobos, Alexander Pisanie, Johannes L. du Gandhi, Ripal T. Kokabi, Nima Tags: How I Do It Source Type: research

Hepatocellular Carcinoma: Advances in Systemic Therapy
This article reviews the evolving landscape of systemic therapies for advanced HCC, emphasizing recent advancements and their impact on patient outcomes. The advent of molecular targeted therapies has transformed HCC management, with sorafenib being the first FDA-approved molecular targeted therapy, setting a standard for a decade. However, recent breakthroughs involve the combination of atezolizumab and bevacizumab, demonstrating superior outcomes over sorafenib, leading to FDA approval in 2020. Another notable combination is tremelimumab and durvalumab, showing efficacy in a multinational phase III trial. Beyond these co...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Selene, Insija Ilyas Ozen, Merve Patel, Reema A. Tags: Review Article Source Type: research

Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma
Semin intervent Radiol 2024; 41: 048-055 DOI: 10.1055/s-0044-1779714Transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) are common liver-directed therapies (LDTs) for unresectable HCC. While both deliver intra-arterial treatment directly to the site of the tumor, they differ in mechanisms of action and side effects. Several studies have compared their side effect profile, time to progression, and overall survival data, but often these lack practical considerations when choosing which treatment modality to use. Many factors can impact operator's choice for treatment, and the choice depends on t...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Behzadi, Ashkan Heshmatzadeh Haghani, Leila D'Souza, Donna L. Flanagan, Siobhan Jones, Christopher Tags: Review Article Source Type: research

Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?
Semin intervent Radiol 2024; 41: 027-047 DOI: 10.1055/s-0043-1777716Liver metastases are the most common malignancy found in the liver and are 20 to 40 times more common than primary hepatic tumors, including hepatocellular carcinoma. Patients with liver metastases often present with advanced disease and are not eligible for curative-intent surgery or ablative techniques. The unique hepatic arterial blood supply of liver metastases allows interventional radiologists to target these tumors with transarterial therapies. Transarterial chemoembolization (TACE) has been studied in the treatment of liver metastases originating f...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: DePietro, Daniel M. Li, Xin Shamimi-Noori, Susan M. Tags: Review Article Source Type: research

Immunoembolization for the Treatment of Uveal Melanoma Hepatic Metastases
Semin intervent Radiol 2024; 41: 020-026 DOI: 10.1055/s-0043-1777712Uveal melanoma is the most common primary intraocular tumor in adults. Approximately 50% of patients develop metastatic disease despite successful treatment of the primary eye tumor. The liver is the most common site of metastatic disease occurring in more than 90% of patients. Clinical prognosis is dependent on the ability to control the growth of liver tumors. Locoregional therapies play an important role in stabilizing liver metastases, prolonging survival for patients with metastatic uveal melanoma. As overall survival is prolonged, the development of ...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Gonsalves, Carin F. Tags: Review Article Source Type: research

Techniques to Optimize Radioembolization Tumor Coverage
Semin intervent Radiol 2024; 41: 016-019 DOI: 10.1055/s-0043-1778659Yttrium-90 (Y90) radioembolization has become a major locoregional treatment option for several primary and secondary liver cancers. Understanding the various factors that contribute to optimal tumor coverage including sphere count, embolization techniques, and catheter choice is important for all interventional radiologists while planning Y90 dosimetry and delivery. Here, we review these factors and the evidence supporting current practice paradigms. [...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Th...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Fassia, M. Kasim Charalel, Resmi Ann Tags: Review Article Source Type: research

Intra-arterial Peptide Receptor Radionuclide Therapy for the Treatment of Hepatic Neuroendocrine Tumor Metastases: Hope or Hype?
Semin intervent Radiol 2024; 41: 011-015 DOI: 10.1055/s-0043-1778658Peptide receptor radionuclide therapy (PRRT) confers significant progression-free survival advantage for patients with small bowel grade 1 and 2 well-differentiated neuroendocrine tumors (WD NET). PRRT may also be clinically beneficial for patients with NET of pancreatic, bronchial, and other sites of origin; patients with paragangliomas; as well as for patients with well-differentiated grade 3 NET. Direct intra-arterial (IA) administration of PRRT into the hepatic artery for patients with NET liver metastases may result in higher radiopharmaceutical dose ...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Khanjyan, Michael V. Fidelman, Nicholas Tags: Review Article Source Type: research

SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know
Semin intervent Radiol 2024; 41: 001-010 DOI: 10.1055/s-0043-1778657This review summarizes the clinical evidence supporting the utilization of stereotactic body radiotherapy (SBRT) for liver tumors, including hepatocellular carcinoma, liver metastases, and cholangiocarcinoma. Emerging prospective evidence has demonstrated the benefit and low rates of toxicity across a broad range of clinical contexts. We provide an introduction for the interventional radiologist, with a discussion of underlying themes such as tumor dose–response, mitigation of liver toxicity, and the technical considerations relevant to performing liver ...
Source: Seminars in Interventional Radiology - March 14, 2024 Category: Radiology Authors: Gutman, Michael J. Serra, Lucas M. Koshy, Matthew Katipally, Rohan R. Tags: Review Article Source Type: research

Intravascular Ultrasound-Guided Retrieval of a Radiolucent Foreign Body from the Superior Vena Cava
Semin intervent Radiol 2023; 40: 549-552 DOI: 10.1055/s-0043-1777713 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - January 24, 2024 Category: Radiology Authors: Rostami, Sara Miller, Jacob Grandhi, Nikhil Ray, Charles E. Kord, Ali Tags: Morbidity & Mortality Source Type: research

Endometriosis: An Overview
Semin intervent Radiol 2023; 40: 544-548 DOI: 10.1055/s-0043-1777748 Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USAArticle in Thieme eJournals: Table of contents  |  Full text (Source: Seminars in Interventional Radiology)
Source: Seminars in Interventional Radiology - January 24, 2024 Category: Radiology Authors: Agnihotri, Tanvir Ghosh, Abheek Lamba, Ashley Ray, Charles E. Tags: Clinical Corner Source Type: research

A Review of Resection and Surgical Ablation for Primary and Secondary Liver Cancers
Semin intervent Radiol 2023; 40: 536-543 DOI: 10.1055/s-0043-1777747The surgical management of primary and secondary liver tumors is constantly evolving. Patient selection, particularly with regard to determining resectability, is vital to the success of programs directed toward invasive treatments of liver tumors. Particular attention should be paid toward determining whether patients are best served with surgical resection or ablative therapies. A multidisciplinary approach is necessary to provide optimal care to patients with liver malignancy. [...] Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New Yor...
Source: Seminars in Interventional Radiology - January 24, 2024 Category: Radiology Authors: White, McKenzie J. Jensen, Eric H. Brauer, David G. Tags: Review Article Source Type: research